Top Markets
Coin of the day
BELLUS Health Inc. BELLUS Health Inc.

BELLUS Health Inc.

BLU
Rankning i aktier #6896
BELLUS Health Inc. is a biopharmaceutical firm in the clinical development... BELLUS Health Inc. is a biopharmaceutical firm in the clinical development phase, dedicated to creating new therapeutic options for intractable chronic cough (RCC) and various other conditions characterized by heightened cough sensitivity. The company's primary investigational compound, BLU-5937, functions as a P2X3 receptor antagonist. This drug is currently progressing through Phase II clinical trials, where it is being assessed for its potential in treating both RCC and persistent itching. Founded in 1993, BELLUS Health Inc. is headquartered in Laval, Canada.
Aktiekurs
$14.30
Senast synkroniserad: 2023-06-29
Marknadsvärde
$1.81B
Förändring (1 dag)
-2.81%
Förändring (1 år)
0.00%
Land
CA
Handel BELLUS Health Inc. (BLU)

Kategori

Aktiekurshistorik för BELLUS Health Inc. (BLU)
Högsta slutkurs: $14.62 den 2023-06-01

Lägsta slutkurs: $617.12 den 2000-06-01
Aktiekurshistorik för BELLUS Health Inc. från 2000 till 2026
Årlig aktiekursutveckling
År Prestanda
2023 56.80%
2022 31.13%
2021 132.06%
2020 -56.49%
2019 141.94%
2018 161.76%
2017 54.42%
2016 -72.16%
2015 -39.98%
2014 212.05%
2013 -6.93%
2012 -69.52%
2011 -61.15%
2010 -32.03%
2009 -57.70%
2008 -83.40%
2007 -89.98%
2006 82.43%
2005 -27.25%
2004 -7.64%
2003 313.71%
2002 87.44%
2001 -57.20%
2000 0.00%
Aktiekurs för liknande företag eller konkurrenter
Företag Aktiekurs Förändring 1år% Land
$548.36 39.87%
US
$1.06K 50.29%
NL
$121.22 -12.71%
AU
$140.81 475.44%
US
$765.25 7.74%
CH